Yttrium-90 (90Y) brachytherapy for squamous carcinoma: Treatment of the conjunctiva, cornea, and sclera
Purpose: Patients with conjunctival squamous cell carcinoma that present with persisting disease or recurrence following topical chemotherapy and/or surgery especially when invading the sclera are challenging to treat. Herein, we describe the use of high-dose-rate (HDR), FDA-cleared, yttrium-90 (90Y...
Principais autores: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Elsevier
2024-12-01
|
coleção: | American Journal of Ophthalmology Case Reports |
Assuntos: | |
Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2451993624001671 |